drugset / Trial / NCT00144287
Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study evaluated the safety and tolerability of tipranavir to improve treatment options for HIV type 1-infected patients who have been previously treated and whose treatment is no longer effective.
Timeline
- Start
- 2004-05
- Primary completion
- 2006-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tipranavir | Small molecule | 500 mg | — |
| Background | Ritonavir | Other / unclassified | 200 mg | — |